Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0C3MW
|
||||
| Former ID |
DIB001027
|
||||
| Drug Name |
MBO7133
|
||||
| Indication | Liver cancer [ICD9: 140-229, 155, 203.0; ICD10:C22] | Phase 1/2 | [1] | ||
| Company |
Metabasis Therapeutics Inc
|
||||
| Target and Pathway | |||||
| Target(s) | Human DNA | Target Info | Binder | [2] | |
| References | |||||
| REF 1 | Clinical pipeline report, company report or official report of Metabasis Therapeutics (2006). | ||||
| REF 2 | Novel Cox-2 Inhibitor for Breast Cancer Therapy. Temple University School of Medicine Philadelphia, Pennsylvania 19140. July 2004. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.